{"url_path":"/sec/pstv/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1095981/0001193125-26-226978-index.html","accession_number":"0001193125-26-226978","cik":"0001095981","ticker":"PSTV","issuer_name":"PLUS THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1095981/0001193125-26-226978-index.html","primary_entity_key":"0001095981","primary_entity_name":"PLUS THERAPEUTICS, INC."},"word_count":36,"has_tables":true,"body_markdown":"Item 1A. Risk Factors\n\nThere have been no material changes to the risk factors disclosed in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2025."}